28514301|t|Unusual axillary metastasis of recurrent nasopharyngeal cancer: A case report
28514301|a|Nasopharyngeal carcinoma (NPC) has a high propensity of metastasis. The most commonly described sites of distant metastasis are the bones, lungs, and liver, whereas axillary metastasis is seldom reported. We hereby present the case of a 66-year-old man with NPC, cT2N2M0, at diagnosis. He had completed chemoradiotherapy and been disease-free for 7 years. After that period, late recurrence in the form of a solitary axillary lymph node metastasis was detected and confirmed by core-needle biopsy. The lesion was chemoresistant but responded to salvage radiotherapy at a dose of 65 Gy in 21 fractions. Post-radiotherapy positron emission tomography scan showed no evidence of disease. We suggested that long-term follow-up of NPC patients is important because a late relapse may occur at an unusual site. Aggressive management of solitary metastasis may achieve good outcome.
28514301	0	7	Unusual	T080	C2700116
28514301	8	27	axillary metastasis	T191	C0684830
28514301	31	40	recurrent	T079	C2945760
28514301	41	62	nasopharyngeal cancer	T191	C0153392
28514301	78	102	Nasopharyngeal carcinoma	T191	C2931822
28514301	104	107	NPC	T191	C2931822
28514301	134	144	metastasis	T046	C4255448
28514301	174	179	sites	T029	C0005898
28514301	191	201	metastasis	T046	C4255448
28514301	210	215	bones	T023	C0262950
28514301	217	222	lungs	T023	C0024109
28514301	228	233	liver	T023	C0023884
28514301	243	262	axillary metastasis	T191	C0684830
28514301	305	309	case	T077	C1706256
28514301	327	330	man	T032	C0086582
28514301	336	339	NPC	T191	C2931822
28514301	341	348	cT2N2M0	T185	C0475284
28514301	353	362	diagnosis	T033	C0011900
28514301	381	398	chemoradiotherapy	T061	C0436307
28514301	408	420	disease-free	T081	C0242793
28514301	427	432	years	T079	C0439234
28514301	458	468	recurrence	T046	C2825055
28514301	486	525	solitary axillary lymph node metastasis	UnknownType	C0741344
28514301	530	538	detected	T033	C0442726
28514301	543	552	confirmed	T033	C0750484
28514301	556	574	core-needle biopsy	T060	C1318309
28514301	580	586	lesion	T033	C0221198
28514301	591	605	chemoresistant	T039	C1514892
28514301	623	643	salvage radiotherapy	T061	C1522449
28514301	649	653	dose	T081	C0034620
28514301	698	731	positron emission tomography scan	T060	C0032743
28514301	739	761	no evidence of disease	T033	C1518340
28514301	781	800	long-term follow-up	T058	C1517942
28514301	804	816	NPC patients	T101	C0030705
28514301	840	852	late relapse	T033	C4054664
28514301	869	881	unusual site	T029	C0005898
28514301	883	904	Aggressive management	T058	C0376636
28514301	917	927	metastasis	T046	C4255448
28514301	945	952	outcome	T080	C0085415